Variant report

Variant	nsv596048
Chromosome Location	chr4:166127619-166129032
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:166128689-166128731	K562	blood:	n/a	n/a
2	ARID3A	chr4:166128621-166128911	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:166129030-166129091	K562	blood:	n/a	n/a
4	ATF1	chr4:166128531-166128845	K562	blood:	n/a	n/a
5	ATF3	chr4:166128654-166128843	GM12878	blood:	n/a	n/a
6	ATF3	chr4:166128608-166128920	K562	blood:	n/a	n/a
7	BHLHE40	chr4:166128304-166129269	GM12878	blood:	n/a	chr4:166129145-166129161 chr4:166128730-166128746 chr4:166129150-166129166 chr4:166128955-166128971 chr4:166128910-166128926 chr4:166128729-166128745 chr4:166129099-166129115 chr4:166129142-166129158
8	BHLHE40	chr4:166128688-166129218	K562	blood:	n/a	chr4:166129145-166129161 chr4:166128730-166128746 chr4:166129150-166129166 chr4:166128955-166128971 chr4:166128910-166128926 chr4:166128729-166128745 chr4:166129099-166129115 chr4:166129142-166129158
9	BRCA1	chr4:166127967-166128035	GM12878	blood:	n/a	n/a
10	BRCA1	chr4:166128391-166128400	GM12878	blood:	n/a	n/a
11	CCNT2	chr4:166128393-166129240	K562	blood:	n/a	n/a
12	CEBPD	chr4:166128437-166128893	HepG2	liver:	n/a	n/a
13	CHD1	chr4:166128216-166128360	GM12878	blood:	n/a	n/a
14	CHD2	chr4:166128381-166129193	Hela-S3	cervix:	n/a	chr4:166129156-166129166
15	CHD2	chr4:166127687-166127742	HepG2	liver:	n/a	n/a
16	CHD2	chr4:166128187-166128254	GM12878	blood:	n/a	n/a
17	CREB1	chr4:166128401-166129030	K562	blood:	n/a	n/a
18	CREB1	chr4:166128426-166128913	K562	blood:	n/a	n/a
19	CREB1	chr4:166128422-166129405	GM12878	blood:	n/a	n/a
20	CREB1	chr4:166128056-166129241	HepG2	liver:	n/a	n/a
21	CREB1	chr4:166128473-166128990	H1-hESC	embryonic stem cell:	n/a	n/a
22	CREB1	chr4:166128405-166128979	A549	lung:	n/a	n/a
23	CREB1	chr4:166128572-166128887	A549	lung:	n/a	n/a
24	CREB1	chr4:166128471-166128989	HepG2	liver:	n/a	n/a
25	CREB1	chr4:166128418-166128980	H1-hESC	embryonic stem cell:	n/a	n/a
26	CTBP2	chr4:166128291-166129366	H1-hESC	embryonic stem cell:	n/a	n/a
27	CTCF	chr4:166128840-166128990	GM12874	blood:	n/a	chr4:166128909-166128922
28	CTCF	chr4:166128888-166128953	NHEK	skin:	n/a	chr4:166128909-166128922
29	CTCF	chr4:166128876-166128948	GM10248	blood:	n/a	chr4:166128909-166128922
30	CTCF	chr4:166128940-166129090	NHEK	skin:	n/a	n/a
31	CTCF	chr4:166128756-166128978	HepG2	liver:	n/a	chr4:166128909-166128922
32	CTCF	chr4:166128780-166128930	GM12869	blood:	n/a	chr4:166128909-166128922
33	CTCF	chr4:166128780-166128930	AG04449	skin:	n/a	chr4:166128909-166128922
34	CTCF	chr4:166128840-166128990	AG04449	skin:	n/a	chr4:166128909-166128922
35	CTCF	chr4:166128858-166128986	MCF-7	breast:	n/a	chr4:166128909-166128922
36	CTCF	chr4:166128820-166128970	GM12864	blood:	n/a	chr4:166128909-166128922
37	CTCF	chr4:166128820-166128970	GM12871	blood:	n/a	chr4:166128909-166128922
38	CTCF	chr4:166128820-166128970	GM12866	blood:	n/a	chr4:166128909-166128922
39	CTCF	chr4:166128840-166128990	GM12875	blood:	n/a	chr4:166128909-166128922
40	CTCF	chr4:166128853-166129001	GM12892	blood:	n/a	chr4:166128909-166128922
41	CTCF	chr4:166128920-166129070	HCPEpiC	choroid plexus:	n/a	n/a
42	CTCF	chr4:166128860-166129010	GM12865	blood:	n/a	chr4:166128909-166128922
43	CTCF	chr4:166128860-166129010	HUVEC	blood vessel:	n/a	chr4:166128909-166128922
44	CTCF	chr4:166128863-166129022	MCF-7	breast:	n/a	chr4:166128909-166128922
45	CTCF	chr4:166128800-166128950	WERI-Rb-1	eye:	n/a	chr4:166128909-166128922
46	CTCF	chr4:166128900-166129050	K562	blood:	n/a	chr4:166128909-166128922
47	CTCF	chr4:166128850-166129012	GM10266	blood:	n/a	chr4:166128909-166128922
48	CTCF	chr4:166128868-166129001	Fibrobl	skin:	n/a	chr4:166128909-166128922
49	CTCF	chr4:166128885-166128977	MCF-7	breast:	n/a	chr4:166128909-166128922
50	CTCF	chr4:166128863-166129004	ProgFib	skin:	n/a	chr4:166128909-166128922

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:166128394-166128444	U87	brain:	n/a
2	chr4:166128480-166128530	HCF	heart:	n/a
3	chr4:166128480-166128530	PANC-1	pancreas:	n/a
4	chr4:166129003-166129053	HUVEC	blood vessel:	n/a
5	chr4:166128394-166128444	NHBE	bronchial:	n/a
6	chr4:166128394-166128444	HAEpiC	amniotic membrane:	n/a
7	chr4:166128480-166128530	HPAEpiC	pulmonary alveolar:	n/a
8	chr4:166128178-166128228	SKMC	muscle:	n/a
9	chr4:166128394-166128444	HRPEpiC	eye:	n/a
10	chr4:166128394-166128444	CMK	blood:	n/a
11	chr4:166128394-166128444	NHDF-neo	bronchial:	n/a
12	chr4:166128480-166128530	CMK	blood:	n/a
13	chr4:166128394-166128444	Caco-2	colon:	n/a
14	chr4:166128480-166128530	SK-N-SH_RA	brain:	n/a
15	chr4:166128394-166128444	HCPEpiC	choroid plexus:	n/a
16	chr4:166128178-166128228	NT2-D1	testis:	n/a
17	chr4:166128394-166128444	HepG2	liver:	n/a
18	chr4:166128480-166128530	HAEpiC	amniotic membrane:	n/a
19	chr4:166128178-166128228	AG10803	skin:	n/a
20	chr4:166129003-166129053	AG10803	skin:	n/a
21	chr4:166128178-166128228	GM06990	blood:	n/a
22	chr4:166129003-166129053	A549	lung:	n/a
23	chr4:166128394-166128444	H1-hESC	embryonic stem cell:	embryo
24	chr4:166128178-166128228	T-47D	breast:	n/a
25	chr4:166128394-166128444	HNPCEpiC	eye:	n/a
26	chr4:166128178-166128228	AG04449	skin:	fetal
27	chr4:166129003-166129053	HEEpiC	esophagus:	n/a
28	chr4:166128394-166128444	NB4	blood:	n/a
29	chr4:166128480-166128530	GM12891	blood:	n/a
30	chr4:166128178-166128228	GM12878	blood:	n/a
31	chr4:166128178-166128228	Caco-2	colon:	n/a
32	chr4:166128178-166128228	HCT-116	colon:	n/a
33	chr4:166129003-166129053	SK-N-SH	brain:	n/a
34	chr4:166128394-166128444	Jurkat	blood:	n/a
35	chr4:166128480-166128530	HRE	kidney:	n/a
36	chr4:166128394-166128444	HMEC	breast:	n/a
37	chr4:166128480-166128530	Hepatocyte	liver:	n/a
38	chr4:166128480-166128530	K562	blood:	n/a
39	chr4:166128178-166128228	PrEC	prostate:	n/a
40	chr4:166128178-166128228	HCPEpiC	choroid plexus:	n/a
41	chr4:166128394-166128444	HL-60	blood:	n/a
42	chr4:166128394-166128444	NT2-D1	testis:	n/a
43	chr4:166128394-166128444	GM12878	blood:	n/a
44	chr4:166128394-166128444	BJ	skin:	n/a
45	chr4:166128480-166128530	AG09309	skin:	n/a
46	chr4:166128394-166128444	AG04450	lung:	fetal
47	chr4:166128394-166128444	SK-N-MC	brain:	n/a
48	chr4:166129003-166129053	NHBE	bronchial:	n/a
49	chr4:166128178-166128228	HepG2	liver:	n/a
50	chr4:166128480-166128530	ovcar-3	ovarian:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:166126423..166128941-chr4:166299614..166301287,2	MCF-7	breast:
2	chr4:166127800..166130090-chr4:166130347..166132969,2	MCF-7	breast:
3	chr4:166127276..166130366-chr4:166247405..166250443,3	K562	blood:
4	chr4:166128531..166130929-chr4:166246215..166249595,5	MCF-7	breast:
5	chr4:166114045..166117632-chr4:166124756..166128607,4	K562	blood:
6	chr4:166126308..166130366-chr4:166247405..166251145,5	K562	blood:
7	chr4:166127386..166130072-chr4:166247171..166250406,6	MCF-7	breast:
8	chr4:166032812..166034984-chr4:166128697..166130341,2	K562	blood:

Variant related genes	Relation type
KLHL2	TF binding region
KLHL2	CpG island
ENSG00000109472	chromatin interactions
ENSG00000170088	chromatin interactions
ENSG00000109466	chromatin interactions
ENSG00000052802	chromatin interactions

Extended variants
information (count: 44 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:44 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11938173	chr4:166127619-166127620	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs548967984	chr4:166127654-166127655	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs146366213	chr4:166127673-166127674	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs112792012	chr4:166127679-166127680	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs138413494	chr4:166127776-166127777	Active TSS Bivalent Enhancer Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs575256025	chr4:166127861-166127862	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs553000642	chr4:166127870-166127871	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs114095469	chr4:166127875-166127876	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs190447965	chr4:166127887-166127888	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs541789822	chr4:166127946-166127947	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs563366632	chr4:166127948-166127949	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs530966515	chr4:166127967-166127968	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs193225108	chr4:166127991-166127992	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs200259849	chr4:166128032-166128033	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs564840632	chr4:166128039-166128040	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs73875504	chr4:166128087-166128088	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs547219931	chr4:166128094-166128095	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs551344455	chr4:166128104-166128105	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
19	rs529836441	chr4:166128113-166128114	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
20	rs548332208	chr4:166128150-166128151	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
21	rs149651087	chr4:166128196-166128197	Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
22	rs116348803	chr4:166128204-166128205	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
23	rs114736033	chr4:166128233-166128234	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
24	rs552183466	chr4:166128234-166128235	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
25	rs144381831	chr4:166128235-166128236	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
26	rs148724963	chr4:166128245-166128246	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
27	rs201177168	chr4:166128290-166128291	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
28	rs534475728	chr4:166128325-166128326	Active TSS Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
29	rs552762746	chr4:166128450-166128451	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
30	rs375966230	chr4:166128509-166128510	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
31	rs535535177	chr4:166128544-166128545	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
32	rs557068904	chr4:166128554-166128555	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
33	rs575541480	chr4:166128634-166128635	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
34	rs546637520	chr4:166128640-166128641	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
35	rs546226453	chr4:166128653-166128654	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
36	rs564577526	chr4:166128726-166128727	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs573491209	chr4:166128741-166128742	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs540795869	chr4:166128773-166128774	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs562245862	chr4:166128793-166128794	Active TSS Bivalent/Poised TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs529545669	chr4:166128833-166128834	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs548295917	chr4:166128877-166128878	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs190204099	chr4:166128911-166128912	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs11547096	chr4:166128965-166128966	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs530377254	chr4:166128994-166128995	Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:70)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Cancer	22429812	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	16272173	CNVD
Breast cancer	17133270	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital anomalies of the kidney and urinary tract	20505237	CNVD
Breast cancer	17393978	CNVD
Testicular germ cell tumor	18059402	CNVD
Ovarian cancer	22174824	CNVD
Olfactory neuroblastoma	18408657	CNVD
Breast cancer	21785460	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21633010	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Cancer	20581869	CNVD
Glioblastoma multiforme	22286061	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	16774939	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Myelofibrosis	22110671	CNVD
intellectual deficit	22127048	CNVD
abnormal development	18461090	CNVD

Chromatin state (count:330 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:166121000-166127800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
2	chr4:166124800-166127800	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr4:166125400-166127800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr4:166125400-166127800	Weak transcription	Gastric	stomach
5	chr4:166126000-166128000	Weak transcription	A549	lung
6	chr4:166126200-166127800	Weak transcription	NH-A	brain
7	chr4:166126800-166127800	Enhancers	Fetal Brain Male	brain
8	chr4:166127000-166127800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
9	chr4:166127200-166127800	Enhancers	Primary T cells fromperipheralblood	blood
10	chr4:166127200-166128400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
11	chr4:166127400-166127800	Enhancers	Primary T helper cells PMA-I stimulated	--
12	chr4:166127400-166127800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr4:166127400-166127800	Enhancers	Primary T killer memory cells from peripheral blood	blood
14	chr4:166127400-166127800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr4:166127400-166127800	Enhancers	Fetal Muscle Trunk	muscle
16	chr4:166127400-166127800	Enhancers	HMEC	breast
17	chr4:166127400-166128400	Flanking Active TSS	Brain Inferior Temporal Lobe	brain
18	chr4:166127400-166128400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
19	chr4:166127600-166127800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
20	chr4:166127600-166127800	Enhancers	H1 Cell Line	embryonic stem cell
21	chr4:166127600-166127800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr4:166127600-166127800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
23	chr4:166127600-166127800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr4:166127600-166127800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr4:166127600-166127800	Enhancers	HUES48 Cell Line	embryonic stem cell
26	chr4:166127600-166127800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
27	chr4:166127600-166127800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr4:166127600-166127800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
29	chr4:166127600-166127800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
30	chr4:166127600-166127800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
31	chr4:166127600-166127800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr4:166127600-166127800	Enhancers	Primary T helper naive cells from peripheral blood	blood
33	chr4:166127600-166127800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
34	chr4:166127600-166127800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
35	chr4:166127600-166127800	Enhancers	Muscle Satellite Cultured Cells	--
36	chr4:166127600-166127800	Enhancers	Cortex derived primary cultured neurospheres	brain
37	chr4:166127600-166127800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr4:166127600-166127800	Weak transcription	Aorta	Aorta
39	chr4:166127600-166127800	Enhancers	Brain Substantia Nigra	brain
40	chr4:166127600-166127800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr4:166127600-166127800	Enhancers	Fetal Lung	lung
42	chr4:166127600-166127800	Enhancers	Placenta	Placenta
43	chr4:166127600-166127800	Enhancers	Lung	lung
44	chr4:166127600-166127800	Enhancers	Ovary	ovary
45	chr4:166127600-166127800	Enhancers	Placenta Amnion	Placenta Amnion
46	chr4:166127600-166127800	Enhancers	Psoas Muscle	Psoas
47	chr4:166127600-166127800	Enhancers	Rectal Mucosa Donor 29	rectum
48	chr4:166127600-166127800	Active TSS	Rectal Smooth Muscle	rectum
49	chr4:166127600-166127800	Enhancers	Right Ventricle	heart
50	chr4:166127600-166127800	Flanking Active TSS	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links